The <em>CHEK2</em> Variant C.349A&gt;G Is Associated with Prostate Cancer Risk and Carriers Share a Common Ancestor

Added 95 days ago (28.04.2021)
Authors: Andreia Brandão; Paula Paulo; Sofia Maia; Manuela Pinheiro; Ana Peixoto; Marta Cardoso; Maria P Silva; Catarina Santos; Rosalind A Eeles; Zsofia Kote-Jarai; Kenneth Muir; None Ukgpcs Collaborators; Johanna Schleutker; Ying Wang; Nora Pashayan; Jyotsna Batra; None Apcb BioResource; Henrik Grönberg; David E Neal; Børge G Nordestgaard; Catherine M Tangen; Melissa C Southey; Alicja Wolk; Demetrius Albanes; Christopher A Haiman; Ruth C Travis; Janet L Stanford; Lorelei A Mucci; Catharine M L West; Sune F Nielsen; Adam S Kibel; Olivier Cussenot; Sonja I Berndt; Stella Koutros; Karina Dalsgaard Sørensen; Cezary Cybulski; Eli Marie Grindedal; Jong Y Park; Sue A Ingles; Christiane Maier; Robert J Hamilton; Barry S Rosenstein; Ana Vega; None The Impact Study Steering Committee And Collaborators; Manolis Kogevinas; Fredrik Wiklund; Kathryn L Penney; Hermann Brenner; Esther M John; Radka Kaneva; Christopher J Logothetis; Susan L Neuhausen; Kim De Ruyck; Azad Razack; Lisa F Newcomb; None Canary Pass Investigators; Davor Lessel; Nawaid Usmani; Frank Claessens; Manuela Gago-Dominguez; Paul A Townsend; Monique J Roobol; None The Profile Study Steering Committee; None The Practical Consortium; Manuel R Teixeira
Read article